You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CALCIJEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Calcijex patents expire, and when can generic versions of Calcijex launch?

Calcijex is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcijex

A generic version of CALCIJEX was approved as calcitriol by TEVA on October 12th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIJEX?
  • What are the global sales for CALCIJEX?
  • What is Average Wholesale Price for CALCIJEX?
Summary for CALCIJEX
Drug patent expirations by year for CALCIJEX
Recent Clinical Trials for CALCIJEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
Roswell Park Cancer InstitutePhase 1
Statistika Consultoria LtdaPhase 4

See all CALCIJEX clinical trials

US Patents and Regulatory Information for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CALCIJEX

See the table below for patents covering CALCIJEX around the world.

Country Patent Number Title Estimated Expiration
Germany 3202622 ⤷  Sign Up
Japan S5544727 ⤷  Sign Up
United Kingdom 2091556 AQUEOUS PREPARATION OF 1A 25-DIHYDROXYCHOLECALCIFEROL ⤷  Sign Up
Canada 962666 1,25-DIHYDROXYCHOLECALIFEROL ⤷  Sign Up
Japan S57144218 STABILIZED DILUTE AQUEOUS MEDICINE OF 1 ALPHA,25-DIHYDROXYCHOLECALCIFEROL FOR NEONATAL ADMINISTRATION ⤷  Sign Up
France 2498450 ⤷  Sign Up
Israel 64798 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.